RBM4 and lung cancer: Here, we demonstrate a non-canonical function of nuclear AURKA to trigger an oncogenic RNA splicing of tumor suppressor RBM4 in a novel m6A reader YTHDC1-dependent mechanism in lung cancer cells, thereby providing a promising avenue for lung cancer therapeutics by targeting nuclear oncogenic signals.